ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers |
|
|
| Recruiting | 1 | 32 | | | Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC | Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause. | | | | |
